Literature DB >> 25963717

mRNA expression levels of hypoxia-induced and stem cell-associated genes in human glioblastoma.

Matthias Bache1, Swetlana Rot1, Jacqueline Keßler1, Antje Güttler1, Henri Wichmann1, Thomas Greither2, Sven Wach3, Helge Taubert3, Ariane Söling4, Udo Bilkenroth5, Matthias Kappler6, Dirk Vordermark1.   

Abstract

The roles of hypoxia-induced and stem cell-associated genes in the development of malignancy and tumour progression are well known. However, there are a limited number of studies analysing the impact of mRNA expression levels of hypoxia-induced and stem cell-associated genes in the tissues of brain tumours and glioblastoma patients. In this study, tumour tissues from patients with glioblastoma multiforme and tumour adjacent tissues were analysed. We investigated mRNA expression levels of hypoxia-inducible factor-1α (HIF-1α), hypoxia-inducible factor-2α (HIF-2α), carbonic anhydrase 9 (CA9), vascular endothelial growth factor (VEGF), glucose transporter-1 (GLUT-1) and osteopontin (OPN), and stem cell-associated genes survivin, epidermal growth factor receptor (EGFR), human telomerase reverse transcriptase (hTERT), Nanog and octamer binding transcription factor 4 (OCT4) using quantitative real-time polymerase chain reaction (qRT-PCR). Our data revealed higher mRNA expression levels of hypoxia-induced and stem cell-associated genes in tumour tissue than levels in the tumour adjacent tissues in patients with glioblastoma multiforme. A strong positive correlation between the mRNA expression levels of HIF-2α, CA9, VEGF, GLUT-1 and OPN suggests a specific hypoxia-associated profile of mRNA expression in glioblastoma multiforme. Additionally, the results indicate the role of stem-cell-related genes in tumour hypoxia. Kaplan-Maier analysis revealed that high mRNA expression levels of hypoxia-induced markers showed a trend towards shorter overall survival in glioblastoma patients (P=0.061). Our data suggest that mRNA expression levels of hypoxia-induced genes are important tumour markers in patients with glioblastoma multiforme.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25963717     DOI: 10.3892/or.2015.3932

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  12 in total

Review 1.  Glucose transport: meeting the metabolic demands of cancer, and applications in glioblastoma treatment.

Authors:  Collin M Labak; Paul Y Wang; Rishab Arora; Maheedhara R Guda; Swapna Asuthkar; Andrew J Tsung; Kiran K Velpula
Journal:  Am J Cancer Res       Date:  2016-08-01       Impact factor: 6.166

Review 2.  Immunotherapy of Primary Brain Tumors: Facts and Hopes.

Authors:  Robin A Buerki; Zinal S Chheda; Hideho Okada
Journal:  Clin Cancer Res       Date:  2018-06-05       Impact factor: 12.531

Review 3.  The role of hypoxic signalling in metastasis: towards translating knowledge of basic biology into novel anti-tumour strategies.

Authors:  Joaquín Araos; Jonathan P Sleeman; Boyan K Garvalov
Journal:  Clin Exp Metastasis       Date:  2018-08-31       Impact factor: 5.150

Review 4.  The role of mRNA in the development, diagnosis, treatment and prognosis of neural tumors.

Authors:  Yiyang Zheng; Yanyan Luo; Xixi Chen; Huiting Li; Baojun Huang; Baofeng Zhou; Liqing Zhu; Xianhui Kang; Wujun Geng
Journal:  Mol Cancer       Date:  2021-03-05       Impact factor: 27.401

5.  Influence of hypoxia and irradiation on osteopontin expression in head and neck cancer and glioblastoma cell lines.

Authors:  Gisela Wohlleben; Agmal Scherzad; Antje Güttler; Dirk Vordermark; Sebastian Kuger; Michael Flentje; Buelent Polat
Journal:  Radiat Oncol       Date:  2015-08-12       Impact factor: 3.481

Review 6.  The Role of Hypoxia in Glioblastoma Invasion.

Authors:  Ana Rita Monteiro; Richard Hill; Geoffrey J Pilkington; Patrícia A Madureira
Journal:  Cells       Date:  2017-11-22       Impact factor: 6.600

7.  Gene silencing of HIF-2α disrupts glioblastoma stem cell phenotype.

Authors:  Leora M Nusblat; Shaili Tanna; Charles M Roth
Journal:  Cancer Drug Resist       Date:  2020-03-11

8.  Correlations between glycolysis with clinical traits and immune function in bladder urothelial carcinoma.

Authors:  Kai Che; Wenkai Han; Xiaokun Yang; Haitao Niu; Danxia Li; Shuxia Cui; Mingxin Zhang
Journal:  Biosci Rep       Date:  2021-02-26       Impact factor: 3.840

9.  GLUT1 and TUBB4 in Glioblastoma Could be Efficacious Targets.

Authors:  Maheedhara R Guda; Collin M Labak; Sara Ibrahim Omar; Swapna Asuthkar; Subra Airala; Jack Tuszynski; Andrew J Tsung; Kiran K Velpula
Journal:  Cancers (Basel)       Date:  2019-09-05       Impact factor: 6.639

10.  The low doses of SWCNTs affect the expression of proliferation and apoptosis related genes in normal human astrocytes.

Authors:  Olha V Rudnytska; Olena O Khita; Dmytro O Minchenko; Dariia O Tsymbal; Yuliia V Yefimova; Myroslava Y Sliusar; Oleksandr Minchenko
Journal:  Curr Res Toxicol       Date:  2021-02-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.